期刊
MOLECULAR CELL
卷 32, 期 2, 页码 180-189出版社
CELL PRESS
DOI: 10.1016/j.molcel.2008.08.031
关键词
-
资金
- National Cancer Institute
- Dr. Miriam and Sheldon Adelson Medical Research Foundation
- Prostate Cancer Foundation (Israel) Center of Excellence
- Yad Abraham Center for Cancer Diagnosis and Therapy [R37ES05777, 2P30CA021765]
- American Lebanese Syrian Associated Charities (ALSAC)
Mdm2 regulates the p53 tumor suppressor by promoting its proteasome-mediated degradation. Mdm2 and p53 engage in an autoregulatory feedback loop that maintains low p53 activity in nonstressed cells. We now report that Mdm2 regulates p53 levels also by targeting ribosomal protein L26. L26 binds p53 mRNA and augments its translation. Mdm2 binds L26 and drives its polyubiquitylation and proteasomal degradation. In addition, the binding of Mdm2 to L26 attenuates the association of L26 with p53 mRNA and represses L26-mediated augmentation of p53 protein synthesis. Under nonstressed conditions, both mechanisms help maintain low cellular p53 levels by constitutively tuning down p53 translation. In response to genotoxic stress, the inhibitory effect of Mdm2 on L26 is attenuated, enabling a rapid increase in p53 synthesis. The Mdm2-L26 interaction thus represents an additional important component of the autoregulatory feedback loop that dictates cellular p53 levels and activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据